Contact directory profile

Mike Piatak


Head, Quantitative Molecular Diagnostics Core at National Cancer Institute
Access Contact Details

Mike Piatak's Contact Information

LinkedIn URL linkedin.com/in/micen -2b5sor
Tel. (Company) +1 800-422-XXXX
Company National Cancer Institute
Residence United States, Maryland, Frederick
Last updated 2023-05-02
Remove my information

Access Contact Details


Directors provide strategic vision, leadership, planning and direction with regards to the organization's operations.
Other job titles include Chief Executive Officer (CEO) and President.
Gain insight from our directors, who can provide effective guidance to help reach organizational goals.
Contact Directors like Mike Piatak



Career Opportunities at National Cancer Institute

Explore career opportunities at National Cancer Institute on our website.
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.



Mike Piatak's current details

Current Title
Head, Quantitative Molecular Diagnostics Core
Type of Role
Director
 just 3% from United States work as a Director
Job functions
Operations
Job Seniority
Higher Management
  8% from United States are employed in Higher Management
Current Industry
Research and Analysis Secensor edc ensoredcensor edc ensoredce nsoredc ensoredc
Location
United States, Maryland, Frederick
Experience (tracked since 2018)
▪ c ensore experience at National Cancer Institute
▪ ce nsore experience as Head, Quantitative Molecular Diagnostics Core
LinkedIn profile
linkedin.com/in/micen -2b5sor


Gain access to all information



Company "National Cancer Institute"

Company size
censo redcens
Website
https://ncifrederick.cancer.gov
Linkedin Profile
https://linkedin.com/company/laborcen cell-bisor
Industrial Field
Biotechnology and Molecular Biology Research
Headquarter
United States, Maryland, Frederick
Full Company Profile
National Cancer Institute

Mike Piatak's Work History
data available since 2018

  • 2023 (6 months)
    National Cancer Institute
    United States
    Head, Quantitative Molecular Diagnostics Core
    Research and Analysis Services
    National Cancer Institute
    https://linkedin.com/company/laboratory-of-cell-biology
  • 20XX (1+ censo)
    Qcensoredcen soredcens
    Ucenso redcen
    Hcen
    Rcensore dce nsoredce nsoredce
  • 20XX (3+ censo)
    Ncensore dcenso redcensor
    Ucenso redcen
    Hcens oredcensored censoredc ensoredcens ored
    Rcensore dce nsoredce nsoredce
    https://linkedin.com/company/laborcen cell-bisor
Access full work history


Frequently asked questions

What company does Mike Piatak work for?
Mike Piatak is working for National Cancer Institute
What is Mike Piatak's title at National Cancer Institute?
Mike's title is , Head, Quantitative Molecular Diagnostics Core
What is Mike Piatak's Seniority at National Cancer Institute?
Mike Piatak has been with National Cancer Institute for 6 months and is in Higher Management
For how long is Mike Piatak working as a Head, Quantitative Molecular Diagnostics Core?
Mike Piatak has 1+ years experience as Head, Quantitative Molecular Diagnostics Core.
What are Mike Piatak's functions as a Head, Quantitative Molecular Diagnostics Core ?
Mike Piatak is responsible for Operacenso
What is Mike Piatak's company phone number?
Mike Piatak's company phone number is +1 800-422-****
What is Mike Piatak's LinkedIn profile ?
Mike Piatak's LinkedIn profile can be found at https://linkedin.com/in/mi***k-2b5***
Who are Mike Piatak's colleagues at National Cancer Institute?
Some of Mike Piatak's colleagues are Alan Perantoni, Stephanie Halling, Amy Huter-imming, Stephen Lockett, Michael Marino, Nadya Tarasova.

Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy and we do not endorse or guarantee the products or services of any company or individual listed.